Mirae Asset Global Investments’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.93M | Sell |
109,086
-4,632
| -4% | -$167K | 0.01% | 523 |
|
|
2025
Q1 | $3.57M | Buy |
113,718
+38,650
| +51% | +$1.21M | 0.01% | 529 |
|
|
2024
Q4 | $1.9M | Sell |
75,068
-966
| -1% | -$24.5K | 0.01% | 680 |
|
|
2024
Q3 | $2.14M | Sell |
76,034
-12,842
| -14% | -$362K | 0.01% | 614 |
|
|
2024
Q2 | $2.37M | Buy |
88,876
+30,242
| +52% | +$807K | 0.01% | 538 |
|
|
2024
Q1 | $1.79M | Sell |
58,634
-30,264
| -34% | -$925K | ﹤0.01% | 1256 |
|
|
2023
Q4 | $2.5M | Buy |
88,898
+8,908
| +11% | +$250K | 0.01% | 1159 |
|
|
2023
Q3 | $2.17M | Buy |
79,990
+40,582
| +103% | +$1.1M | ﹤0.01% | 1147 |
|
|
2023
Q2 | $1.21M | Buy |
39,408
+20,340
| +107% | +$625K | ﹤0.01% | 1455 |
|
|
2023
Q1 | $687K | Buy |
19,068
+857
| +5% | +$30.9K | ﹤0.01% | 1757 |
|
|
2022
Q4 | $720K | Sell |
18,211
-7,702
| -30% | -$304K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $1.04M | Buy |
+25,913
| New | +$1.04M | ﹤0.01% | 1458 |
|
|
2022
Q2 | – | Sell |
-17,008
| Closed | -$662K | – | 2438 |
|
|
2022
Q1 | $662K | Buy |
17,008
+695
| +4% | +$27.1K | ﹤0.01% | 1406 |
|
|
2021
Q4 | $650K | Buy |
16,313
+1,676
| +11% | +$66.8K | ﹤0.01% | 1401 |
|
|
2021
Q3 | $529K | Buy |
+14,637
| New | +$529K | ﹤0.01% | 1474 |
|
|
2021
Q2 | – | Sell |
-22,481
| Closed | -$981K | – | 1730 |
|
|
2021
Q1 | $981K | Sell |
22,481
-1,998
| -8% | -$87.2K | ﹤0.01% | 1137 |
|
|
2020
Q4 | $1.23M | Buy |
+24,479
| New | +$1.23M | ﹤0.01% | 1084 |
|